Collaboration. Acceleration. Results.      1 877 TO FIX MS
Myelin Repair Foundation Home Page Donate to Myelin Repair Foundation

Newsroom

Here is a listing of our current media-related activities and resources along with links to our archive:

Recent Media Coverage

The New Exploratory Urge, May 2014
Life Science Leader, Life Science Partnerships With Patient Foundations: The Best Practices, June 2, 2014
Pharmaceutical Executive, Pushing the Boundaries of MS Research: The Myelin Repair Foundation, February 28, 2014
Multiple Sclerosis Discovery Forum, MS Research Roundup: February 12, 2014
BioNews Texas, Multiple Sclerosis Myelin Repair, Neuroprotection Drug To Be Tested In New Research Collaboration, February 3, 2014
Bio-IT World, January News and Product Briefs, January 2014
NeuroNews, Myelin Repair Foundation and NIH enter into agreement to repurpose MRF-008 for multiple sclerosis, January 29, 2014
BioNews Texas, Promising Multiple Sclerosis Study Involving NIH, Myelin Repair Foundation Seeks To Repurpose Hypertension Drug To Stimulate Repair In MS, January 28, 2014
San Francisco Business Times, A new way: Foundation lines up generic heart drug for multiple sclerosis trial, January 27, 2014
The New York Times, In the Long War on Poverty, Small Victories That Matter, January 8, 2014
Patient Pioneers — Biocentury TV, November 3, 2013
The Huffington Post, What Now: It Still Takes Too Long and Costs Too Much, October 31, 2013
Genetic Engineering & Biotechnology News, Biogen Idec, Myelin Repair Foundation Eye New Mouse Model Against MS, July 1, 2013
View entire articles and press coverage archive.

- Back to top -

Recent Press Releases

Conrad N. Hilton Foundation Grants Myelin Repair Foundation $1.35 Million Matching Grant to Support Myelin Repair Research (November 24, 2014)
Myelin Repair Foundation Announces Long-Term European Partnership with Hertie Foundation (August 11, 2014)
Bionure Inc.’s MS Drug Candidate Shows Positive Results for Myelin Repair in Cell Culture Assay (May 27, 2014)
The Myelin Repair Foundation and NIH Enter Agreement for the Clinical Development of MRF-008, a Drug Repurposing Opportunity for Multiple Sclerosis (January 27, 2014)
View entire press release archive.

- Back to top -

Background Information

Myelin Repair Foundation Overview (PDF)
The Myelin Repair Foundation's Translational Medicine Platform (PDF)
View entire background and whitepaper archive.

- Back to top -

Video Interviews and Talks

Hear Myelin Repair Foundation CEO Scott Johnson talk about how we're accelerating research for myelin repair therapeutic drugs for multiple sclerosis.

Mendel's Pod:
When Drug Discovery Gets Personal

Watch When Drug Discovery Gets Personal

12Gurus 2012:
Where are the Cures?

Media Contact

Karen Dua
Phone: 408-871-2410
Email: karen@myelinrepair.org